Subsequent studies have shown that HE4 is elevated in 90% of serous ovarian cancer cases and in most cases of endometrioid and clear cell cancer, whereas mucinous and germ cell tumors rarely express HE4 [14]. This evidence concerns the gene WFDC2 and germ cell tumor.